Clinical Trial: Immunogenicity of Double‐Dose Versus Standard‐Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease
Double-dose HBV vaccination significantly improved AIR and EIR over standard-dose. These findings support a double-dose strategy to optimize seroconversion in patients with IBD, especially those receiving immunosuppressive therapy.
Authors
- Ashutosh Ishan Yadav (ORCID: https://orcid.org/0000-0002-5954-8738)
- Ritin Mohindra (ORCID: https://orcid.org/0000-0003-4224-898X)
- Jimil Shah (ORCID: https://orcid.org/0000-0001-5773-912X)
- Vikas Suri (ORCID: https://orcid.org/0000-0001-6379-2744)
- Vaneet Jearth (ORCID: https://orcid.org/0000-0002-5633-0338)
- Roop Kishor Soni
- Abhirup Chatterjee (ORCID: https://orcid.org/0000-0001-5777-5390)
- Anupam Singh (ORCID: https://orcid.org/0000-0002-7610-1807)
- Chhagan Lal Birda (ORCID: https://orcid.org/0000-0002-5564-4917)
- Arun Sharma (ORCID: https://orcid.org/0000-0001-5945-4224)
- Usha Dutta (ORCID: https://orcid.org/0000-0002-9435-3557)
- Vishal Sharma
- Amol N. Patil
Institutions
- All India Institute of Medical Sciences Jodhpur (IN)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/apt.70470
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71